About this event
This interactive panel discussion will give you a realistic view of the challenges and pitfalls of precision medicine clinical trials.
Maria Antonietta-Cerone, Precision Medicine Porfolio Manager, CRUK
Alastair Greystoke, Clinical Senior Lecturer/ Hon Consultant, Newcastle University Hospital
Donald White, Precision Medicine Manager, CRUK
Gary Middleton, Professor, University of Birmingham
Pauline Rehal, Principal Clinical Scientist, West Midlands Regional Genetics Laboratory
Mark Ross, Senior Director, Illumina
Cancer will affect 1 in 2 people over the course of their lifetime, and as we move towards an ever more personalised health system, the need for personalised cancer treatments is growing. The FDA has strongly recommended integrating genomics into clinical trials, but it comes with an array of challenges from trial design, reporting and clinical decision making while waiting for results.
While integrating genomics into trials hold a lot of promises, there are pitfalls to avoid. Learn from lessons learned from large nationwide CRUK trials, with a focus on simplifying the process to get the most meaningful results.
This discussion covers the promises and pitfalls of running large-scale precision cancer trials.
Attendees will leave with:
The panel consists of an array of experts from across the trial process: from the trial organisers to oncologists, overcoming the challenges together to make cancer care personal.
Front Line Genomics is a genomics-focused media company, with a social mission to deliver the benefits of genomics to patients faster. We organise the Festival of Genomics, digital events, reports, webinars and digital events, as well as operating a content-rich website.
Share this event